Loading ...
Sorry, an error occurred while loading the content.

Med-Brief 980225

Expand Messages
  • sptcher@worldnetla.net
    Med-Brief from Intelligent Network Concepts, Inc. Wednesday, February 25, 1998 _________________________________________________________________ GENERAL NEWS *
    Message 1 of 1 , Feb 28, 1998
    • 0 Attachment
      Med-Brief
      from
      Intelligent Network Concepts, Inc.

      Wednesday, February 25, 1998

      _________________________________________________________________

      GENERAL NEWS

      * A recent report suggests that there is a small risk of bone
      marrow transplant recipients developing diabetes after
      receiving bone marrow from diabetic donors.
      - European researchers reviewed data from 17,000 bone marrow
      transplant cases to collect data after findings one case
      in which diabetes was apparently transferred from a
      donor to a recipient.
      - authors concluded that there is a real risk of transferring
      diabetes from bone marrow donors to recipients, but
      suggest that the risk is so small as to not warrant
      the exclusion of an otherwise eligible donor simply
      because they have diabetes.
      - the report is in The Lancet (1998;351:568-569).


      DRUGS, PRODUCTS, AND POLICY

      * Researchers have reported the development of a drug which
      aids in the evaluation of a tumor's oxygen content, a
      measure which will enable treatments to be better fine-
      tuned to individuals.
      - researchers at the University of Pennsylvania Cancer Center
      say the drug, EF5, binds to tumor cells which thrive
      in oxygen-deprived environments (hypoxic), which are
      known to be more resistant to radiation and chemotherapy
      treatment that other cancer cells.
      - authors say the drug has recently been approved for
      Phase I clinical trials by the FDA and that it is
      hoped that the drug can be adapted for use with
      Positron Emission Tomography (PET) imaging.
      - data taken from a University of Pennsylvania Cancer Center
      release (February 24, 1998).
    Your message has been successfully submitted and would be delivered to recipients shortly.